Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-019880
Filing Date
2023-02-13
Accepted
2023-02-13 17:20:40
Documents
1
Group Members
FORESITE CAPITAL MANAGEMENT V, LLCFORESITE CAPITAL OPPORTUNITY FUND V, L.P.FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLCJAMES B. TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236260d2_sc13ga.htm SC 13G/A 97935
  Complete submission text file 0001104659-23-019880.txt   99720
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Subject) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90878 | Film No.: 23620017
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund V, L.P. (Filed by) CIK: 0001792204 (see all company filings)

EIN.: 843449937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A